RYR1 and Malignant hyperthermia: Actionable variants in both cardiovascular disease-related and cancer-related genes affect more than 1% of the population and we also observed a high frequency of GPPs with variants in RYR1 (12%; 62/508) associated with Malignant hyperthermia (Fig. 3C).